Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif
about
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypesHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsA single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivityHIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchMultiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allSuppression of APOBEC3-mediated restriction of HIV-1 by VifStructural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3FStructural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloBMultiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.Identification of HIV-1 Vif regions required for CBF-β interaction and APOBEC3 suppressionNovel approaches to inhibiting HIV-1 replication.Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded VifIdentification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.Characterization of RNA binding and chaperoning activities of HIV-1 Vif protein. Importance of the C-terminal unstructured tail.Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.Structural insights for HIV-1 therapeutic strategies targeting Vif.Insights into the dual activity of SIVmac239 Vif against human and African green monkey APOBEC3G.Requirement of HIV-1 Vif C-terminus for Vif-CBF-β interaction and assembly of CUL5-containing E3 ligaseIdentification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteinsStructural Features of Antiviral APOBEC3 Proteins are Linked to Their Functional Activities.The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3HRedoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1.Structure of the Vif-binding domain of the antiviral enzyme APOBEC3GHydrodynamic and functional analysis of HIV-1 Vif oligomerization.Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 VifRunning loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif proteinHIV-1 Adapts To Replicate in Cells Expressing Common Marmoset APOBEC3G and BST2Host restriction factors in retroviral infection: promises in virus-host interaction.Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.Human cellular restriction factors that target HIV-1 replication.HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain.Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.
P2860
Q24612992-B08CCEF9-39F7-42C9-8695-7611DAFCC3AFQ24619114-48257DDE-4BF5-4B90-85F3-07AF11779DFAQ24656551-669E6BCD-EF49-4AB8-984F-0ACC266A35EEQ26746070-2A727562-2CE1-47CF-9A7A-28B36490E1CDQ26823568-5C182D85-C7B9-4CC7-8CEF-213B30591EB7Q27025150-D6CD723E-C6E2-474F-8CDB-02F87D3542F7Q27680506-F138BF05-72EF-4124-B998-316A3C54D8E2Q28540150-F43600BF-7AB4-4DCD-A75B-A223647E25BEQ30381745-E2402567-A492-4A6D-A84F-D9457FA8B9B1Q33583855-F56F396F-9940-45A5-AD5A-E267C5AC60F7Q33624690-47039E06-3BF6-49CF-AFE9-F3D7871BE0A4Q33815187-250A3177-B591-4762-B8B0-359EDCFC7DABQ33826857-67D2D692-794C-45F2-8988-1C78F85DAB19Q33877364-D6900EF4-0C2A-415B-8B06-A19FE45BFB05Q34039510-7C58C1B6-907D-4FD2-ADEA-BBEC0719375CQ34039514-23DC223D-4215-4F0A-9C33-EDA5EFB0A594Q34055413-82F84D66-CCF1-4E22-941B-082A8CFF5172Q34266485-6F0D8AF3-2159-4C6A-826F-639C7AAB80B4Q34416665-8D590AE4-F924-4811-9140-80D7737827AEQ34433647-5503506C-609A-46DC-A9F8-3F684ADA6BBEQ34493717-C97C50F6-E202-4B5A-931F-55BB568E8FD0Q34695564-C5690B89-4BBA-476B-9D8B-55C12792E455Q35451347-23BBCBF0-06A5-4B44-B5CE-00C129B1A0D6Q35531709-4E34A13A-9F7D-4793-9CF9-C538A2D7EF0BQ35627352-F03247F7-7C3F-4542-A951-444273EC8276Q35666084-147BF67A-4CBC-4F8B-B9FF-52982E5C7FD2Q35682519-B96F3F62-308D-42BB-BABF-43A08BEB0A88Q35685282-5A8E9F35-DE83-404F-A2C9-6F2EA7AAC487Q35827946-B2CEDA1E-DE44-4CF3-BCD5-4046AD755A2CQ36181649-D4CDD128-7FE8-44C1-A0ED-16BD0343DEC3Q36432758-7F5939B0-8826-4640-BFF8-003C0D0884E5Q36434202-BC16D8B1-A56C-478A-B4C1-23778F0CAB27Q36548179-7072A5F0-FDC4-473E-A09F-CAB98BADAF07Q37333725-4D8BFCAC-EEB5-414E-ABDD-D6FD2EF2D889Q37333859-4A157CF7-0F3A-48D5-B4BD-861A8C4DEE5BQ37382519-719B850C-D8D5-4F08-8B2A-720C89691B25Q37410890-441AF88E-B7D3-471B-9E15-DCAA60A19106Q37599297-0F15F2EE-7154-452E-A15F-6E2FA201D171Q37605560-44CC19FB-07FA-45FC-BF78-9528CBB88DE4Q37643789-CE8C6401-E01D-403A-8A07-A4DB5723B53F
P2860
Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulation of APOBEC3 proteins ...... unodeficiency virus SIVagm Vif
@en
Regulation of APOBEC3 proteins ...... nodeficiency virus SIVagm Vif.
@nl
type
label
Regulation of APOBEC3 proteins ...... unodeficiency virus SIVagm Vif
@en
Regulation of APOBEC3 proteins ...... nodeficiency virus SIVagm Vif.
@nl
prefLabel
Regulation of APOBEC3 proteins ...... unodeficiency virus SIVagm Vif
@en
Regulation of APOBEC3 proteins ...... nodeficiency virus SIVagm Vif.
@nl
P2093
P2860
P356
P1433
P1476
Regulation of APOBEC3 proteins ...... unodeficiency virus SIVagm Vif
@en
P2093
Andrew Jay Brazier
Dana Gabuzda
Kottampatty S Rajendran
P2860
P304
P356
10.1128/JVI.01898-08
P407
P577
2008-12-24T00:00:00Z